tiprankstipranks

Daniel Lochner Insider Profile

4 Followers
Daniel Lochner, CFO at Oyster Point Pharma, holds 4.62K shares in Tectonic Therapeutic (Ticker: TECX), holds 0.00 shares in Oyster Point Pharma (Ticker: OYST). Most recently, Daniel Lochner Bought ― shares of Tectonic Therapeutic on Feb 07, 2025 for an estimated value of 249.96K.
tipranks
Daniel Lochner

Daniel Lochner
Oyster Point Pharma (OYST)
CFO

Ranked #40,929 out of 100,516 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+17.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$136K
100.00%
A breakdown of Daniel Lochner's holdings

Insider Roles

Tectonic Therapeutic
(TECX)
CFO
Roles that Daniel Lochner holds in companies

Most Profitable Insider Trade

Stock:
Oyster Point Pharma
(OYST)
Rating:Informative Buy
Date:Nov 05, 2019 - Nov 05, 2020
Return:+34.90%
The most profitable trade made by Daniel Lochner

Daniel Lochner's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
OYST
Oyster Point Pharma
Jan 04, 2023
Uninformative Sell
10.97K
$0.00
Tectonic Therapeutic
Feb 07, 2025
CFO
Informative Buy
249.96K
$136.39K
List of latest transactions for each holding click on a transaction to see Daniel Lochner's performance on stock

Daniel Lochner insider profile FAQ

What is the percentage of profitable transactions made by Daniel Lochner?
The percentage of profitable transactions made by Daniel Lochner is 50%.
    What is the average return per transaction made by Daniel Lochner?
    The average return per transaction made by Daniel Lochner is 17.40%.
      What stocks does Daniel Lochner hold?
      Daniel Lochner holds: OYST, TECX stocks.
        What was Daniel Lochner’s latest transaction?
        Daniel Lochner latest transaction was an Informative Buy of $249.96K.
          What was Daniel Lochner's most profitable transaction?
          Daniel Lochner’s most profitable transaction was an Informative Buy of OYST stock on November 5, 2019. The return on the trade was 34.90%.
            What is Daniel Lochner's role in Oyster Point Pharma?
            Daniel Lochner's role in Oyster Point Pharma is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.